Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Trimble Inc (NASDAQ: TRMB) closed at $57.86 in the last session, down -1.08% from day before closing price of $58.49. In other words, the price has decreased by -$1.08 from its previous closing price. On the day, 0.91 million shares were traded. TRMB stock price reached its highest trading level at $58.69 during the session, while it also had its lowest trading level at $57.75.
Ratios:
We take a closer look at TRMB’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 61.86 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.61. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on February 13, 2024, Upgraded its rating to Overweight and sets its target price to $68 from $51 previously.
On September 29, 2023, Raymond James Upgraded its rating to Outperform which previously was Mkt Perform but kept the price unchanged to $65.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 16 ’24 when SCHWARTZ MARK DAVID sold 2,322 shares for $59.10 per share. The transaction valued at 137,230 led to the insider holds 10,265 shares of the business.
Large Peter sold 1,447 shares of TRMB for $85,518 on Apr 16 ’24. The Senior Vice President now owns 8,220 shares after completing the transaction at $59.10 per share. On Apr 15 ’24, another insider, SCHWARTZ MARK DAVID, who serves as the Senior VP, CES of the company, sold 235 shares for $61.14 each. As a result, the insider received 14,368 and left with 12,587 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TRMB now has a Market Capitalization of 14129874944 and an Enterprise Value of 17203259392. As of this moment, Trimble’s Price-to-Earnings (P/E) ratio for their current fiscal year is 46.29, and their Forward P/E ratio for the next fiscal year is 19.12. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.63. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.74 while its Price-to-Book (P/B) ratio in mrq is 3.17. Its current Enterprise Value per Revenue stands at 4.529 whereas that against EBITDA is 21.049.
Stock Price History:
Over the past 52 weeks, TRMB has reached a high of $65.55, while it has fallen to a 52-week low of $39.57. The 50-Day Moving Average of the stock is -5.00%, while the 200-Day Moving Average is calculated to be 9.03%.
Shares Statistics:
According to the various share statistics, TRMB traded on average about 1.50M shares per day over the past 3-months and 1439060 shares per day over the past 10 days. A total of 246.50M shares are outstanding, with a floating share count of 244.39M. Insiders hold about 0.53% of the company’s shares, while institutions hold 95.89% stake in the company. Shares short for TRMB as of 1711584000 were 2897873 with a Short Ratio of 1.93, compared to 1709164800 on 3684777. Therefore, it implies a Short% of Shares Outstanding of 2897873 and a Short% of Float of 1.34000005.
Earnings Estimates
The market rating for Trimble Inc (TRMB) is a result of the insights provided by TORM plc analysts actively involved in the assessment.The consensus estimate for the next quarter is $57.86, with high estimates of $25.73 and low estimates of $15.66.
Analysts are recommending an EPS of between $Financial Services and $Healthcare for the fiscal current year, implying an average EPS of $Technology.
